In the CML cohort, only CML-PB-SC-4 and CML-PB-SC-6 expressed HLA-A*02:01, but all patients were predicted to have HLA-A alleles capable of presenting RMF. This evidence concerns the gene HLA-A and chronic myelogenous leukemia, BCR-ABL1 positive.